Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
RNA, Transfer | 18 | 2023 | 316 | 3.380 |
Why?
|
RNA Processing, Post-Transcriptional | 14 | 2023 | 436 | 3.330 |
Why?
|
Sequence Analysis, RNA | 16 | 2023 | 2012 | 2.880 |
Why?
|
Guanosine | 7 | 2021 | 61 | 2.510 |
Why?
|
RNA, Ribosomal | 11 | 2024 | 245 | 2.210 |
Why?
|
High-Throughput Nucleotide Sequencing | 15 | 2021 | 3595 | 2.110 |
Why?
|
RNA | 17 | 2023 | 2749 | 1.850 |
Why?
|
Pseudouridine | 4 | 2023 | 24 | 1.840 |
Why?
|
Methylation | 23 | 2024 | 1106 | 1.660 |
Why?
|
Cytidine | 2 | 2021 | 68 | 1.430 |
Why?
|
Methyltransferases | 9 | 2023 | 367 | 1.290 |
Why?
|
RNA, Fungal | 3 | 2018 | 164 | 1.250 |
Why?
|
RNA, Small Untranslated | 2 | 2021 | 76 | 1.210 |
Why?
|
RNA, Viral | 8 | 2022 | 2901 | 1.170 |
Why?
|
Ribosomes | 6 | 2024 | 500 | 0.950 |
Why?
|
RNA, Messenger | 16 | 2023 | 13035 | 0.910 |
Why?
|
Ribonucleoproteins | 6 | 2021 | 381 | 0.810 |
Why?
|
RNA Viruses | 1 | 2021 | 124 | 0.710 |
Why?
|
Cytosine | 1 | 2021 | 216 | 0.700 |
Why?
|
Protein Biosynthesis | 5 | 2022 | 2126 | 0.670 |
Why?
|
Saccharomyces cerevisiae | 8 | 2022 | 2751 | 0.650 |
Why?
|
Gene Products, rev | 2 | 2011 | 31 | 0.620 |
Why?
|
Plasma | 1 | 2021 | 575 | 0.600 |
Why?
|
Gene Library | 5 | 2021 | 1074 | 0.540 |
Why?
|
Chemistry Techniques, Analytical | 1 | 2015 | 49 | 0.500 |
Why?
|
RNA, Ribosomal, 18S | 4 | 2022 | 62 | 0.490 |
Why?
|
RNA, Small Nucleolar | 4 | 2024 | 31 | 0.490 |
Why?
|
RNA, Bacterial | 4 | 2021 | 390 | 0.470 |
Why?
|
Aniline Compounds | 1 | 2018 | 986 | 0.470 |
Why?
|
Nucleotides | 3 | 2022 | 464 | 0.450 |
Why?
|
tat Gene Products, Human Immunodeficiency Virus | 2 | 2011 | 127 | 0.430 |
Why?
|
Hydrolysis | 3 | 2019 | 682 | 0.430 |
Why?
|
Adenosine | 5 | 2021 | 825 | 0.400 |
Why?
|
Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2011 | 15 | 0.400 |
Why?
|
Ribose | 2 | 2023 | 68 | 0.390 |
Why?
|
Reverse Transcription | 2 | 2020 | 47 | 0.370 |
Why?
|
Drosophila melanogaster | 6 | 2024 | 1708 | 0.360 |
Why?
|
Quality Control | 3 | 2019 | 841 | 0.360 |
Why?
|
RNA Stability | 3 | 2022 | 321 | 0.350 |
Why?
|
HEK293 Cells | 8 | 2023 | 4208 | 0.340 |
Why?
|
Biology | 2 | 2021 | 295 | 0.330 |
Why?
|
Toll-Like Receptor 7 | 2 | 2020 | 172 | 0.320 |
Why?
|
Immunity, Innate | 5 | 2022 | 2962 | 0.320 |
Why?
|
Electrophoresis, Capillary | 2 | 2021 | 64 | 0.320 |
Why?
|
Spectrophotometry, Ultraviolet | 2 | 2021 | 220 | 0.320 |
Why?
|
Alternative Splicing | 6 | 2020 | 1117 | 0.320 |
Why?
|
RNA Splicing | 3 | 2014 | 908 | 0.310 |
Why?
|
MicroRNAs | 2 | 2021 | 3751 | 0.310 |
Why?
|
Bacillus subtilis | 2 | 2021 | 359 | 0.300 |
Why?
|
Gene Expression Regulation | 7 | 2021 | 12073 | 0.300 |
Why?
|
Radiotherapy, Intensity-Modulated | 2 | 2013 | 806 | 0.290 |
Why?
|
RNA, Untranslated | 4 | 2023 | 453 | 0.280 |
Why?
|
RNA Precursors | 2 | 2022 | 209 | 0.280 |
Why?
|
Vitamin B 12 | 2 | 2020 | 527 | 0.270 |
Why?
|
HIV-1 | 5 | 2019 | 6939 | 0.270 |
Why?
|
Cytoplasm | 4 | 2021 | 1536 | 0.270 |
Why?
|
tRNA Methyltransferases | 3 | 2020 | 53 | 0.270 |
Why?
|
Eukaryotic Cells | 2 | 2019 | 198 | 0.250 |
Why?
|
Tandem Mass Spectrometry | 4 | 2023 | 1157 | 0.240 |
Why?
|
HeLa Cells | 8 | 2021 | 3130 | 0.240 |
Why?
|
Nucleoside Q | 1 | 2023 | 2 | 0.230 |
Why?
|
RNA-Binding Proteins | 6 | 2020 | 1903 | 0.220 |
Why?
|
Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2002 | 33 | 0.220 |
Why?
|
Ribonucleoproteins, Small Nucleolar | 1 | 2022 | 8 | 0.220 |
Why?
|
RNA-Directed DNA Polymerase | 2 | 2020 | 248 | 0.220 |
Why?
|
Nanopores | 1 | 2023 | 50 | 0.220 |
Why?
|
Thalidomide | 1 | 2008 | 890 | 0.220 |
Why?
|
Gene Products, tat | 1 | 2002 | 120 | 0.210 |
Why?
|
Neoadjuvant Therapy | 1 | 2013 | 2727 | 0.210 |
Why?
|
RNA, Ribosomal, 28S | 1 | 2022 | 13 | 0.210 |
Why?
|
Drosophila Proteins | 4 | 2014 | 1703 | 0.210 |
Why?
|
Computational Biology | 4 | 2019 | 3519 | 0.210 |
Why?
|
Optic Atrophy | 1 | 2022 | 79 | 0.200 |
Why?
|
Regulatory Sequences, Ribonucleic Acid | 2 | 2012 | 32 | 0.200 |
Why?
|
RNA, Transfer, Phe | 1 | 2021 | 7 | 0.200 |
Why?
|
DNA, Ribosomal | 2 | 2023 | 290 | 0.200 |
Why?
|
Interferon Type I | 2 | 2022 | 542 | 0.190 |
Why?
|
Chromosomal Proteins, Non-Histone | 3 | 2022 | 735 | 0.190 |
Why?
|
Chemical Fractionation | 1 | 2021 | 65 | 0.190 |
Why?
|
Nucleic Acid Conformation | 6 | 2018 | 913 | 0.190 |
Why?
|
RNA, Double-Stranded | 1 | 2022 | 290 | 0.190 |
Why?
|
Oxidoreductases | 2 | 2020 | 424 | 0.190 |
Why?
|
5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2020 | 30 | 0.190 |
Why?
|
2-Aminopurine | 1 | 2020 | 13 | 0.190 |
Why?
|
Chromatography, Gel | 1 | 2021 | 668 | 0.180 |
Why?
|
Escherichia coli | 4 | 2021 | 4217 | 0.180 |
Why?
|
Arabidopsis | 1 | 2023 | 459 | 0.180 |
Why?
|
Hydrazines | 1 | 2021 | 226 | 0.180 |
Why?
|
Databases, Nucleic Acid | 1 | 2021 | 211 | 0.180 |
Why?
|
Ions | 1 | 2020 | 265 | 0.170 |
Why?
|
Ribosome Subunits, Large, Eukaryotic | 1 | 2019 | 9 | 0.170 |
Why?
|
Vitamin B 12 Deficiency | 1 | 2020 | 116 | 0.170 |
Why?
|
Ribosome Subunits, Small, Eukaryotic | 1 | 2019 | 19 | 0.170 |
Why?
|
Genetic Variation | 1 | 2015 | 6542 | 0.170 |
Why?
|
Prokaryotic Cells | 1 | 2019 | 48 | 0.170 |
Why?
|
Isotope Labeling | 1 | 2021 | 406 | 0.170 |
Why?
|
Mass Spectrometry | 3 | 2021 | 2204 | 0.170 |
Why?
|
Codon, Nonsense | 1 | 2020 | 281 | 0.160 |
Why?
|
Acetals | 1 | 2018 | 6 | 0.160 |
Why?
|
Spectrometry, Fluorescence | 1 | 2021 | 688 | 0.160 |
Why?
|
Spasms, Infantile | 1 | 2022 | 305 | 0.160 |
Why?
|
Cranial Irradiation | 2 | 2011 | 401 | 0.160 |
Why?
|
Peroxiredoxins | 1 | 2018 | 51 | 0.150 |
Why?
|
Xenopus laevis | 1 | 2022 | 957 | 0.150 |
Why?
|
Humans | 48 | 2023 | 744366 | 0.150 |
Why?
|
Brain Edema | 1 | 2022 | 617 | 0.150 |
Why?
|
Chromatography, Liquid | 4 | 2023 | 976 | 0.150 |
Why?
|
Manganese | 1 | 2020 | 408 | 0.150 |
Why?
|
Maternal Health Services | 1 | 2023 | 455 | 0.150 |
Why?
|
DNA Transposable Elements | 1 | 2021 | 748 | 0.150 |
Why?
|
DNA, Complementary | 1 | 2021 | 2050 | 0.150 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2020 | 730 | 0.150 |
Why?
|
Herpesvirus 4, Human | 1 | 2022 | 1041 | 0.150 |
Why?
|
Exons | 5 | 2021 | 2439 | 0.140 |
Why?
|
Gene Silencing | 2 | 2021 | 1539 | 0.140 |
Why?
|
Sulfhydryl Compounds | 1 | 2018 | 298 | 0.140 |
Why?
|
Ribosomal Proteins | 1 | 2019 | 360 | 0.140 |
Why?
|
Proteome | 2 | 2023 | 1798 | 0.140 |
Why?
|
Fluorescence | 2 | 2019 | 751 | 0.140 |
Why?
|
Prostatic Neoplasms | 3 | 2023 | 11126 | 0.140 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2022 | 570 | 0.140 |
Why?
|
Endosomes | 1 | 2019 | 519 | 0.140 |
Why?
|
Nucleic Acids | 1 | 2018 | 182 | 0.140 |
Why?
|
Oogenesis | 2 | 2014 | 131 | 0.140 |
Why?
|
Nuclear Proteins | 5 | 2023 | 5856 | 0.130 |
Why?
|
Metabolism, Inborn Errors | 1 | 2018 | 288 | 0.130 |
Why?
|
Toll-Like Receptors | 1 | 2019 | 593 | 0.130 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2013 | 11525 | 0.130 |
Why?
|
Saccharomyces cerevisiae Proteins | 2 | 2022 | 1887 | 0.130 |
Why?
|
Cell Nucleus | 3 | 2021 | 2969 | 0.130 |
Why?
|
Cartilage, Articular | 1 | 2023 | 1095 | 0.130 |
Why?
|
Epistasis, Genetic | 1 | 2018 | 365 | 0.130 |
Why?
|
Gene Expression Regulation, Viral | 2 | 2011 | 442 | 0.130 |
Why?
|
Polyethylene Glycols | 1 | 2021 | 1182 | 0.130 |
Why?
|
Osteoarthritis | 1 | 2023 | 1036 | 0.130 |
Why?
|
Neuroblastoma | 1 | 2023 | 1226 | 0.130 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2017 | 486 | 0.120 |
Why?
|
Molecular Structure | 1 | 2018 | 1899 | 0.120 |
Why?
|
Quality of Life | 3 | 2023 | 12802 | 0.120 |
Why?
|
Neurodegenerative Diseases | 1 | 2022 | 1061 | 0.110 |
Why?
|
Antigen Presentation | 1 | 2019 | 1284 | 0.110 |
Why?
|
Oligonucleotides | 1 | 2016 | 572 | 0.110 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2019 | 1366 | 0.110 |
Why?
|
Protein Binding | 5 | 2019 | 9384 | 0.110 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2023 | 1414 | 0.100 |
Why?
|
Cell Line | 3 | 2021 | 16000 | 0.100 |
Why?
|
Vinblastine | 1 | 2013 | 502 | 0.100 |
Why?
|
Drug Discovery | 1 | 2020 | 1058 | 0.100 |
Why?
|
Base Sequence | 6 | 2024 | 12797 | 0.100 |
Why?
|
Rous sarcoma virus | 1 | 2010 | 4 | 0.100 |
Why?
|
Transcription, Genetic | 3 | 2023 | 7721 | 0.100 |
Why?
|
Breast Neoplasms | 3 | 2013 | 20824 | 0.100 |
Why?
|
nef Gene Products, Human Immunodeficiency Virus | 1 | 2011 | 153 | 0.090 |
Why?
|
Nucleocytoplasmic Transport Proteins | 1 | 2010 | 76 | 0.090 |
Why?
|
Mesenchymal Stem Cells | 1 | 2020 | 1632 | 0.090 |
Why?
|
Multiple Myeloma | 1 | 2008 | 5181 | 0.090 |
Why?
|
Polypyrimidine Tract-Binding Protein | 1 | 2009 | 26 | 0.090 |
Why?
|
Fluorouracil | 1 | 2013 | 1619 | 0.080 |
Why?
|
Antineoplastic Agents | 2 | 2011 | 13693 | 0.080 |
Why?
|
Virus Replication | 2 | 2022 | 2535 | 0.080 |
Why?
|
Cells, Cultured | 2 | 2023 | 19233 | 0.080 |
Why?
|
Gene Deletion | 1 | 2016 | 2751 | 0.080 |
Why?
|
Multiprotein Complexes | 1 | 2014 | 1120 | 0.080 |
Why?
|
Molecular Conformation | 2 | 2020 | 562 | 0.080 |
Why?
|
Proteins | 1 | 2022 | 6100 | 0.070 |
Why?
|
Mutation | 4 | 2022 | 29786 | 0.070 |
Why?
|
Biological Transport | 1 | 2012 | 2120 | 0.070 |
Why?
|
Radiotherapy Dosage | 2 | 2013 | 2879 | 0.070 |
Why?
|
Bacterial Proteins | 1 | 2020 | 3854 | 0.070 |
Why?
|
Animals | 15 | 2024 | 168768 | 0.070 |
Why?
|
Genes, p53 | 2 | 2020 | 755 | 0.070 |
Why?
|
X Chromosome | 1 | 2010 | 814 | 0.070 |
Why?
|
Radiation Injuries | 2 | 2013 | 1180 | 0.070 |
Why?
|
Interferons | 2 | 2020 | 706 | 0.070 |
Why?
|
Sensitivity and Specificity | 1 | 2021 | 14723 | 0.070 |
Why?
|
Gene Knockdown Techniques | 2 | 2022 | 1656 | 0.060 |
Why?
|
Algorithms | 2 | 2022 | 13882 | 0.060 |
Why?
|
Carrier Proteins | 1 | 2018 | 5023 | 0.060 |
Why?
|
Drosophila | 1 | 2011 | 1491 | 0.060 |
Why?
|
rev Gene Products, Human Immunodeficiency Virus | 1 | 2002 | 28 | 0.060 |
Why?
|
Silencer Elements, Transcriptional | 1 | 2002 | 11 | 0.060 |
Why?
|
Exonucleases | 1 | 2022 | 47 | 0.050 |
Why?
|
Sepharose | 1 | 2022 | 108 | 0.050 |
Why?
|
RNA-Binding Protein FUS | 1 | 2023 | 72 | 0.050 |
Why?
|
Software | 1 | 2017 | 4441 | 0.050 |
Why?
|
Transcription Factors | 1 | 2022 | 12207 | 0.050 |
Why?
|
Binding Sites | 3 | 2010 | 6111 | 0.050 |
Why?
|
Neural Plate | 1 | 2022 | 12 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2021 | 19905 | 0.050 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2002 | 300 | 0.050 |
Why?
|
Anticodon | 1 | 2021 | 25 | 0.050 |
Why?
|
Phosphoproteins | 1 | 2011 | 2441 | 0.050 |
Why?
|
Autoimmune Diseases of the Nervous System | 1 | 2022 | 67 | 0.050 |
Why?
|
Deamination | 1 | 2021 | 26 | 0.050 |
Why?
|
HIV Infections | 2 | 2023 | 16715 | 0.050 |
Why?
|
Viral Proteins | 1 | 2009 | 1900 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2021 | 6773 | 0.050 |
Why?
|
T-Lymphocytes | 1 | 2019 | 10183 | 0.050 |
Why?
|
Electron Transport | 1 | 2021 | 211 | 0.050 |
Why?
|
Androgen Antagonists | 1 | 2009 | 1377 | 0.050 |
Why?
|
Dexamethasone | 1 | 2008 | 1951 | 0.050 |
Why?
|
Oligoribonucleotides | 1 | 2020 | 51 | 0.050 |
Why?
|
Mitochondrial Membranes | 1 | 2021 | 174 | 0.050 |
Why?
|
Nervous System Malformations | 1 | 2022 | 247 | 0.050 |
Why?
|
Ribonucleosides | 1 | 2020 | 82 | 0.050 |
Why?
|
Nucleosides | 1 | 2021 | 138 | 0.050 |
Why?
|
Base Pairing | 1 | 2020 | 141 | 0.050 |
Why?
|
Anti-Retroviral Agents | 1 | 2010 | 1714 | 0.040 |
Why?
|
RNA Interference | 2 | 2020 | 2890 | 0.040 |
Why?
|
Codon | 1 | 2021 | 611 | 0.040 |
Why?
|
Brain Neoplasms | 2 | 2011 | 8861 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2011 | 8642 | 0.040 |
Why?
|
Neural Crest | 1 | 2022 | 275 | 0.040 |
Why?
|
Problem-Based Learning | 1 | 2023 | 361 | 0.040 |
Why?
|
Survival Rate | 1 | 2013 | 12788 | 0.040 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2002 | 1723 | 0.040 |
Why?
|
Parturition | 1 | 2023 | 441 | 0.040 |
Why?
|
Xenopus Proteins | 1 | 2022 | 433 | 0.040 |
Why?
|
Neoplasm Staging | 1 | 2013 | 11031 | 0.040 |
Why?
|
Thymidine | 1 | 2018 | 310 | 0.040 |
Why?
|
Repressor Proteins | 1 | 2010 | 3024 | 0.040 |
Why?
|
Fibroblasts | 2 | 2020 | 4162 | 0.040 |
Why?
|
Tanzania | 1 | 2023 | 1346 | 0.040 |
Why?
|
Cell Line, Tumor | 3 | 2021 | 16690 | 0.040 |
Why?
|
Immunologic Surveillance | 1 | 2019 | 93 | 0.040 |
Why?
|
Molecular Sequence Data | 3 | 2010 | 18111 | 0.040 |
Why?
|
Hydrogen | 1 | 2018 | 164 | 0.040 |
Why?
|
RNA, Ribosomal, 5.8S | 1 | 2017 | 4 | 0.040 |
Why?
|
Oocytes | 2 | 2014 | 1188 | 0.040 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2020 | 504 | 0.040 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2021 | 506 | 0.040 |
Why?
|
Animals, Genetically Modified | 2 | 2014 | 1549 | 0.040 |
Why?
|
Eye | 1 | 2022 | 729 | 0.040 |
Why?
|
Chondrocytes | 1 | 2023 | 804 | 0.040 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2009 | 3617 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2017 | 4751 | 0.040 |
Why?
|
Follow-Up Studies | 3 | 2013 | 39052 | 0.040 |
Why?
|
Prospective Studies | 2 | 2013 | 53290 | 0.040 |
Why?
|
Ribonuclease III | 1 | 2019 | 275 | 0.040 |
Why?
|
DNA, Mitochondrial | 1 | 2021 | 817 | 0.030 |
Why?
|
Sequence Alignment | 1 | 2021 | 2256 | 0.030 |
Why?
|
Azacitidine | 1 | 2018 | 347 | 0.030 |
Why?
|
Green Fluorescent Proteins | 1 | 2021 | 2088 | 0.030 |
Why?
|
DEAD-box RNA Helicases | 1 | 2019 | 375 | 0.030 |
Why?
|
Middle Aged | 6 | 2013 | 213390 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2013 | 21748 | 0.030 |
Why?
|
Prognosis | 2 | 2013 | 29060 | 0.030 |
Why?
|
Mitochondrial Proteins | 1 | 2021 | 994 | 0.030 |
Why?
|
Influenza A virus | 1 | 2019 | 456 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2013 | 6364 | 0.030 |
Why?
|
Oxygen Consumption | 1 | 2021 | 1868 | 0.030 |
Why?
|
Microsatellite Repeats | 1 | 2017 | 802 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2019 | 1341 | 0.030 |
Why?
|
Iron | 1 | 2023 | 1774 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2021 | 8432 | 0.030 |
Why?
|
Protein Engineering | 1 | 2017 | 538 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2011 | 9274 | 0.030 |
Why?
|
Aged | 5 | 2013 | 163288 | 0.030 |
Why?
|
Mice, Nude | 1 | 2020 | 3689 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2023 | 2943 | 0.030 |
Why?
|
Cell Culture Techniques | 1 | 2021 | 1678 | 0.030 |
Why?
|
Kinetics | 1 | 2021 | 6476 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2012 | 12262 | 0.030 |
Why?
|
Family Health | 1 | 2018 | 1281 | 0.030 |
Why?
|
Up-Regulation | 1 | 2021 | 4222 | 0.030 |
Why?
|
Urinary Bladder Diseases | 1 | 2013 | 166 | 0.030 |
Why?
|
RNA Transport | 1 | 2012 | 48 | 0.030 |
Why?
|
Genetic Loci | 1 | 2021 | 2575 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2018 | 1837 | 0.020 |
Why?
|
Heterozygote | 1 | 2018 | 2804 | 0.020 |
Why?
|
Male | 6 | 2023 | 350115 | 0.020 |
Why?
|
Histones | 1 | 2021 | 2598 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2017 | 2715 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2021 | 2917 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2022 | 2987 | 0.020 |
Why?
|
Female | 8 | 2023 | 380193 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2019 | 1480 | 0.020 |
Why?
|
Pedigree | 1 | 2018 | 4642 | 0.020 |
Why?
|
Interspersed Repetitive Sequences | 1 | 2010 | 54 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2017 | 4740 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2011 | 906 | 0.020 |
Why?
|
Mitochondria | 1 | 2021 | 3514 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2013 | 57776 | 0.020 |
Why?
|
Chromosomes, Human, X | 1 | 2010 | 296 | 0.020 |
Why?
|
Infertility, Female | 1 | 2014 | 788 | 0.020 |
Why?
|
Caspases | 1 | 2011 | 928 | 0.020 |
Why?
|
Genome, Human | 1 | 2021 | 4420 | 0.020 |
Why?
|
X Chromosome Inactivation | 1 | 2010 | 224 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2021 | 3646 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2019 | 2725 | 0.020 |
Why?
|
Cell Survival | 1 | 2017 | 5882 | 0.020 |
Why?
|
Models, Molecular | 1 | 2017 | 5451 | 0.020 |
Why?
|
Proteomics | 1 | 2020 | 3638 | 0.020 |
Why?
|
DNA | 1 | 2021 | 7294 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2018 | 3799 | 0.020 |
Why?
|
3' Untranslated Regions | 1 | 2009 | 513 | 0.020 |
Why?
|
Mice | 3 | 2021 | 81201 | 0.020 |
Why?
|
Gastrointestinal Tract | 1 | 2013 | 814 | 0.020 |
Why?
|
Urinary Bladder | 1 | 2013 | 1173 | 0.020 |
Why?
|
Alleles | 1 | 2018 | 6933 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9735 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2021 | 10483 | 0.020 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2009 | 794 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2011 | 2649 | 0.020 |
Why?
|
Gastrointestinal Diseases | 1 | 2013 | 1170 | 0.020 |
Why?
|
Adult | 3 | 2013 | 214052 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2021 | 5263 | 0.010 |
Why?
|
Paclitaxel | 1 | 2011 | 1708 | 0.010 |
Why?
|
DNA Methylation | 1 | 2017 | 4285 | 0.010 |
Why?
|
Neurons | 1 | 2023 | 9340 | 0.010 |
Why?
|
Blotting, Western | 1 | 2011 | 5181 | 0.010 |
Why?
|
Phylogeny | 1 | 2010 | 2804 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2022 | 25628 | 0.010 |
Why?
|
Pregnancy | 1 | 2023 | 29144 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18034 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 21833 | 0.010 |
Why?
|
Melanoma | 1 | 2019 | 5511 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 2019 | 5692 | 0.010 |
Why?
|
Time Factors | 1 | 2021 | 40075 | 0.010 |
Why?
|
Incidence | 1 | 2013 | 20952 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2011 | 9240 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2009 | 9445 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2011 | 77460 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2011 | 63107 | 0.000 |
Why?
|